Filing Flows › GE HealthCare Technologies (GEHC) › Guidance & outlook

GE HealthCare Technologies (GEHC) guidance and outlook

GE HealthCare Technologies (GEHC) raised some and lowered other parts of its guidance on Oct 28, 2026: Operating margin 15.3% for FY2026; EPS $4.59 for FY2026; Free cash flow $1.5B for FY2026. GE HealthCare Technologies' 10-Q filed Oct 28, 2026 makes 11 forward-looking statements, 0 of them new and 0 no longer said since the filing before.

Guidance and outlook

Latest guidance

From the earnings release filed Oct 28, 2026 (8-K on EDGAR).

Forward-looking statements, 10-Q filed Oct 28, 2026

• Tariffs by the U.S. and several other countries have materially impacted our financial results and should the tariffs continue at current levels, we expect to continue to see a material impact.
• While we are taking actions to mitigate the impact of tariffs, we do not expect that our mitigation actions will fully offset the additional costs or other negative impacts resulting from the tariffs.
• The Company intends to continue to file claims for additional tariff refunds, predominantly related to tariffs incurred in 2025.
• We continue to take action to mitigate the exposures under the current environment by securing supply and identifying opportunities to partially offset cost increases; however, if the current environment continues or deteriorates further, we will continue to see adverse impacts to our results.
• We will continue to apply for licenses to supply to these customers and to support our business in Russia, as required.
• The implementation of these measures affected our ability to supply customers in Russia during the nine months ended September 30, 2026 and 2025 and is expected to continue to do so.
• There is no guarantee we will obtain all of the licenses for which we apply, that any approvals we obtain will be on a timely basis, will remain in effect, or that our business in Russia will not be further disrupted due to evolving legal or operational considerations.
• We will continue to assess whether developments related to the conflict have had, or are reasonably likely to have, a material impact on the Company.
• The non-GAAP financial measures presented in this Quarterly Report on Form 10-Q are supplemental measures of our performance and our liquidity that we believe will help investors understand our financial condition, cash flows, and operating results, and assess our future prospects.
• We plan to continue to rely on capital markets, and we expect to have access to credit facilities to fund our operations.
• The cost and availability of debt financing will be influenced by our credit ratings and market conditions.

GE HealthCare Technologies' latest quarter

Questions

Did GE HealthCare Technologies raise or lower its guidance?

GE HealthCare Technologies (GEHC) raised some and lowered other parts of its guidance on Oct 28, 2026: Operating margin 15.3% for FY2026; EPS $4.59 for FY2026; Free cash flow $1.5B for FY2026.

What does GE HealthCare Technologies expect?

Tariffs by the U.S. and several other countries have materially impacted our financial results and should the tariffs continue at current levels, we expect to continue to see a material impact. While we are taking actions to mitigate the impact of tariffs, we do not expect that our mitigation actions will fully offset the additional costs or other negative impacts resulting from the tariffs. The Company intends to continue to file claims for additional tariff refunds, predominantly related to tariffs incurred in 2025.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.